-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
2',3'-Dideoxyadenosine
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/4097-22-72d.gif)
| Category | Human immunodeficiency Virus (HIV) |
| CAS | 4097-22-7 |
| Description | It is a potent anti-HIV agent. |
Product Information
| Synonyms | 2',3'-Dideoxyadenosine;4097-22-7;dideoxyadenosine;ADENOSINE, 2',3'-DIDEOXY-;ddAdo;((2S,5R)-5-(6-Amino-9H-purin-9-yl)tetrahydrofuran-2-yl)methanol;NSC-98700;NSC 98700;dideoxy adenosine;DIDANOSINE IMPURITY G;D2A;DTXSID2023771;4Q86AH641A;MFCD00010534;NCGC00090791-03;DTXCID203771;[(2S,5R)-5-(6-aminopurin-9-yl)tetrahydrofuran-2-yl]methanol;9-(2,3-Dideoxy-beta-D-glycero-pentofuranosyl)-9H-purin-6-amine (2',3'-Dideoxyadenosine);SMR000677932;CCRIS 428;CAS-4097-22-7;CHEMBL14925;EINECS 223-853-2;BRN 0619924;NSC98700;UNII-4Q86AH641A;[(2S,5R)-5-(6-amino-9H-purin-9-yl)tetrahydrofuran-2-yl]methanol;ddA & GM-CSF;2'-3'-dideoxyadenosine;SCHEMBL3541;DIDEOXYADENOSINE [MI];5-26-16-00256 (Beilstein Handbook Reference);MLS001055366;MLS006010855;CHEMBL23094;[(2S,5R)-5-(6-aminopurin-9-yl)oxolan-2-yl]methanol;DIDEOXYADENOSINE [MART.];CHEBI:91207;HMS3039N07;Tox21_111022;Tox21_201121;AC-332;BDBM50004352;s5979;AKOS015833087;AKOS015896852;CS-W014157;DIDANOSINE IMPURITY G [WHO-IP];HY-W013441;NCGC00090791-01;NCGC00090791-02;NCGC00090791-04;NCGC00258673-01;AS-12357;2',3'-DIDEOXYADENOSINE [WHO-IP];DIDANOSINE IMPURITY G [EP IMPURITY];2',3'-Dideoxyadenosine, >=97% (HPLC);AM20100090;D3065;NS00030891;9-(2,3-Dideoxy-beta-D-ribofuranosyl)adenine;A848008;W-202681;BRD-K84794093-001-07-5;Q27163127;[(2S,5R)-5-(6-amino-9H-purin-9-yl)oxolan-2-yl]methanol;[(2R,5S)-5-(6-Amino-purin-9-yl)-tetrahydro-furan-2-yl]-methanol;2 inverted exclamation marka,3 inverted exclamation marka-Dideoxyadenosine;2',3'-Dideoxyadenosine & Granulocyte-macrophage colony-stimulating factor;6-AMINO-9-(2',3'-DIDEOXY-.BETA.-D-GLYCERO-PENTOFURANOSYL)PURINE;Didanosine impurity G, European Pharmacopoeia (EP) Reference Standard;9-(2,3-DIDEOXY-.BETA.-D-GLYCERO-PENTOFURANOSYL)-9H-PURIN-6-AMINE [WHO-IP];9-(2,3-Dideoxy-beta-D-glycero-pentofuranosyl)-9H-purin-6-amine (2?,3?-Dideoxyadenosine); |
| IUPAC Name | [(2S,5R)-5-(6-aminopurin-9-yl)oxolan-2-yl]methanol |
| Molecular Weight | 235.24 |
| Molecular Formula | C10H13N5O2 |
| Canonical SMILES | OC[C@@H]1CC[C@H](N2C(N=CN=C3N)=C3N=C2)O1 |
| InChI | InChI=1S/C10H13N5O2/c11-9-8-10(13-4-12-9)15(5-14-8)7-2-1-6(3-16)17-7/h4-7,16H,1-3H2,(H2,11,12,13)/t6-,7+/m0/s1 |
| InChIKey | WVXRAFOPTSTNLL-NKWVEPMBSA-N |
| Boiling Point | 539.1°C at 760 mmHg |
| Melting Point | 181-184°C |
| Purity | ≥95% |
| Density | 1.76 g/cm3 |
| Solubility | Soluble in Water, Methanol |
| Appearance | Solid |
| Application | Antimetabolites |
| Storage | 4°C, protect from light *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light) |
